SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 8, 2025 / CASI Pharmaceuticals, Inc. (CASI), a clinical-stage biopharmaceutical company developing CID-103, a potentially best-in-class, ...
LAS VEGAS--(BUSINESS WIRE)-- CID HoldCo, Inc. (DAIC), doing business as Dot Ai (Nasdaq: DAIC) (“Dot Ai” or the “Company”), an IoT and AI-based SaaS company at the forefront of Asset Intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results